The store will not work correctly when cookies are disabled.
4-[(E)-2-(1H-Benzoimidazol-2-yl)-2-cyano-vinyl]-benzonitrile
ID: ALA326328
PubChem CID: 6054543
Max Phase: Preclinical
Molecular Formula: C17H10N4
Molecular Weight: 270.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#C/C(=C\c1ccc(C#N)cc1)c1nc2ccccc2[nH]1
Standard InChI: InChI=1S/C17H10N4/c18-10-13-7-5-12(6-8-13)9-14(11-19)17-20-15-3-1-2-4-16(15)21-17/h1-9H,(H,20,21)/b14-9+
Standard InChI Key: NHYFEKFQPKPKMQ-NTEUORMPSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
0.6875 -1.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2042 -0.7875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5125 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2042 -2.1250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9250 -2.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5833 -1.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9250 -0.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5833 -1.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3417 -0.0125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0417 -2.1417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2167 -2.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7500 -2.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3917 -2.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1542 -2.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1542 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9750 -1.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9792 -2.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2958 -0.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2958 -2.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0083 -1.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0083 -1.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 1 1 0
5 3 2 0
6 2 1 0
7 3 1 0
8 4 1 0
9 7 3 0
10 11 3 0
11 13 1 0
12 5 1 0
13 16 1 0
14 12 2 0
15 12 1 0
16 15 2 0
17 14 1 0
18 6 1 0
19 8 1 0
20 19 2 0
21 18 2 0
8 6 2 0
21 20 1 0
17 13 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 270.30 | Molecular Weight (Monoisotopic): 270.0905 | AlogP: 3.50 | #Rotatable Bonds: 2 |
Polar Surface Area: 76.26 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.53 | CX Basic pKa: 3.64 | CX LogP: 3.55 | CX LogD: 3.55 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.72 | Np Likeness Score: -1.59 |
References
1. Saczewski F, Reszka P, Gdaniec M, Grünert R, Bednarski PJ.. (2004) Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles., 47 (13): [PMID:15189040] [10.1021/jm0311036] |